O’Sullivan is an interventional radiologist — a physician who specializes in minimally invasive, targeted treatments. In mid-March at the Society of Interventional Radiology scientific meeting in ...

Deep vein thrombosis, or DVT, is a potentially life-threatening blood clotting condition. If you’ve ever had DVT or been at risk for this condition, you’ve likely been given drugs to help break up the ...

Giving the anti-clotting drug rivaroxaban to patients for 12 weeks instead of the usual six after a blood clot in the lower leg reduces the risk of further clots developing up to two years after ...

GERRARDS CROSS, England, NICE Final Appraisal Determination recommends that edoxaban is a cost effective use of NHS resources. The National Institute for Health and Care Excellence (NICE) has ...

Given this increased utilization, a research team led by Riyaz Bashir, MD, FACC, RVT, Professor of Medicine at the Lewis Katz School of Medicine at Temple University and Director of Vascular and ...

The disadvantages of dabigatran include a higher cost compared with warfarin, the need for twice-daily dosing, and a slightly increased risk for gastrointestinal bleeding (6.1% with dabigatran vs 4% ...

Thrombosis and embolism are both blood clots that reduce or block blood flow inside your blood vessels. They’re two different yet serious conditions. Here’s a look at the differences and similarities.

Deep vein thrombosis (DVT) is a blood clot (thrombus) in a deep vein, usually in the legs. These clots require medical care right away. These clots are dangerous because they can break loose, travel ...

There are several superficial vein thrombosis treatment options. A person’s symptoms and overall health can influence the type of treatment they receive. Superficial vein thrombosis (SVT), also known ...

This week we are going to discuss two common conditions of the lower extremities which can be a cause for concern and the different strategies for managing them. Cellulitis is a infection of the ...

Researchers sought to determine whether vaccination against COVID-19 would increase the risk of developing deep vein thrombosis. The following article features coverage from the American Society of ...